Altered peptidase and viral-specific T cell response in LMP2 mutant mice. Van Kaer L, Ashton-Rickardt PG, Eichelberger M, Gaczynska M, Nagashima K, Rock KL, Goldberg AL, Doherty PC, Tonegawa S (1994) Immunity 1: 533-41 Structural Basis of Protection against H7N9 Influenza Virus by Human Anti-N9 Neuraminidase Antibodies. Zhu X, Turner HL, Lang S, McBride R, Bangaru S, Gilchuk IM, Yu W, Paulson JC, Crowe JE, Ward AB, Wilson IA (2019) Cell Host Microbe 26: 729-738.e4 Influenza H7N9 Virus Neuraminidase-Specific Human Monoclonal Antibodies Inhibit Viral Egress and Protect from Lethal Influenza Infection in Mice. Gilchuk IM, Bangaru S, Gilchuk P, Irving RP, Kose N, Bombardi RG, Thornburg NJ, Creech CB, Edwards KM, Li S, Turner HL, Yu W, Zhu X, Wilson IA, Ward AB, Crowe JE (2019) Cell Host Microbe 26: 715-728.e8 Expression of the 1918 influenza A virus PB1-F2 enhances the pathogenesis of viral and secondary bacterial pneumonia. McAuley JL, Hornung F, Boyd KL, Smith AM, McKeon R, Bennink J, Yewdell JW, McCullers JA (2007) Cell Host Microbe 2: 240-9 Glycan shielding of the influenza virus hemagglutinin contributes to immunopathology in mice. Wanzeck K, Boyd KL, McCullers JA (2011) Am J Respir Crit Care Med 183: 767-73 Phospholipase D is present on Golgi-enriched membranes and its activation by ADP ribosylation factor is sensitive to brefeldin A. Ktistakis NT, Brown HA, Sternweis PC, Roth MG (1995) Proc Natl Acad Sci U S A 92: 4952-6 The role of influenza and parainfluenza infections in nasopharyngeal pneumococcal acquisition among young children. Grijalva CG, Griffin MR, Edwards KM, Williams JV, Gil AI, Verastegui H, Hartinger SM, Vidal JE, Klugman KP, Lanata CF (2014) Clin Infect Dis 58: 1369-76 CD154 regulates primate humoral immunity to influenza. Crowe JE, Sannella EC, Pfeiffer S, Zorn GL, Azimzadeh A, Newman R, Miller GG, Pierson RN (2003) Am J Transplant 3: 680-8 Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults. Talbot HK, Griffin MR, Chen Q, Zhu Y, Williams JV, Edwards KM (2011) J Infect Dis 203: 500-8 Influenza enhances susceptibility to natural acquisition of and disease due to Streptococcus pneumoniae in ferrets. McCullers JA, McAuley JL, Browall S, Iverson AR, Boyd KL, Henriques Normark B (2010) J Infect Dis 202: 1287-95 Treatment with protein synthesis inhibitors improves outcomes of secondary bacterial pneumonia after influenza. Karlström A, Boyd KL, English BK, McCullers JA (2009) J Infect Dis 199: 311-9 Toll-like receptor 2 mediates fatal immunopathology in mice during treatment of secondary pneumococcal pneumonia following influenza. Karlström A, Heston SM, Boyd KL, Tuomanen EI, McCullers JA (2011) J Infect Dis 204: 1358-66 Rates of hospitalizations for respiratory syncytial virus, human metapneumovirus, and influenza virus in older adults. Widmer K, Zhu Y, Williams JV, Griffin MR, Edwards KM, Talbot HK (2012) J Infect Dis 206: 56-62 Unveiling the burden of influenza-associated pneumococcal pneumonia. Grijalva CG, Griffin MR (2012) J Infect Dis 205: 355-7 Influenza virus resistance to human neutralizing antibodies. Crowe JE (2012) mBio 3: e00213-12 CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo. Assarsson E, Kambayashi T, Sandberg JK, Hong S, Taniguchi M, Van Kaer L, Ljunggren HG, Chambers BJ (2000) J Immunol 165: 3673-9 Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study. Birdwell KA, Ikizler MR, Sannella EC, Wang L, Byrne DW, Ikizler TA, Wright PF (2009) Am J Kidney Dis 54: 112-21 Bedside diagnosis of influenzavirus infections in hospitalized children. Poehling KA, Griffin MR, Dittus RS, Tang YW, Holland K, Li H, Edwards KM (2002) Pediatrics 110: 83-8 Immunopathogenic and antibacterial effects of H3N2 influenza A virus PB1-F2 map to amino acid residues 62, 75, 79, and 82. Alymova IV, Green AM, van de Velde N, McAuley JL, Boyd KL, Ghoneim HE, McCullers JA (2011) J Virol 85: 12324-33 Naturally occurring human monoclonal antibodies neutralize both 1918 and 2009 pandemic influenza A (H1N1) viruses. Krause JC, Tumpey TM, Huffman CJ, McGraw PA, Pearce MB, Tsibane T, Hai R, Basler CF, Crowe JE (2010) J Virol 84: 3127-30 Human monoclonal antibodies to pandemic 1957 H2N2 and pandemic 1968 H3N2 influenza viruses. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Albrecht R, Blum DL, Ramos I, Fernandez-Sesma A, Edwards KM, García-Sastre A, Basler CF, Crowe JE (2012) J Virol 86: 6334-40 Influenza viruses with receptor-binding N1 neuraminidases occur sporadically in several lineages and show no attenuation in cell culture or mice. Hooper KA, Crowe JE, Bloom JD (2015) J Virol 89: 3737-45 A broadly neutralizing human monoclonal antibody that recognizes a conserved, novel epitope on the globular head of the influenza H1N1 virus hemagglutinin. Krause JC, Tsibane T, Tumpey TM, Huffman CJ, Basler CF, Crowe JE (2011) J Virol 85: 10905-8 Seasonality of invasive pneumococcal disease: temporal relation to documented influenza and respiratory syncytial viral circulation. Talbot TR, Poehling KA, Hartert TV, Arbogast PG, Halasa NB, Edwards KM, Schaffner W, Craig AS, Griffin MR (2005) Am J Med 118: 285-91 Phospholipase D facilitates efficient entry of influenza virus, allowing escape from innate immune inhibition. Oguin TH, Sharma S, Stuart AD, Duan S, Scott SA, Jones CK, Daniels JS, Lindsley CW, Thomas PG, Brown HA (2014) J Biol Chem 289: 25405-17 Bacterial sinusitis and otitis media following influenza virus infection in ferrets. Peltola VT, Boyd KL, McAuley JL, Rehg JE, McCullers JA (2006) Infect Immun 74: 2562-7 Duration of virus shedding after trivalent intranasal live attenuated influenza vaccination in adults. Talbot TR, Crocker DD, Peters J, Doersam JK, Ikizler MR, Sannella E, Wright PE, Edwards KM (2005) Infect Control Hosp Epidemiol 26: 494-500 The immune profile associated with acute allergic asthma accelerates clearance of influenza virus. Samarasinghe AE, Woolard SN, Boyd KL, Hoselton SA, Schuh JM, McCullers JA (2014) Immunol Cell Biol 92: 449-59 A chemically programmed antibody is a long-lasting and potent inhibitor of influenza neuraminidase. Hayakawa M, Toda N, Carrillo N, Thornburg NJ, Crowe JE, Barbas CF (2012) Chembiochem 13: 2191-5 Impact of home environment interventions on the risk of influenza-associated ARI in Andean children: observations from a prospective household-based cohort study. Budge PJ, Griffin MR, Edwards KM, Williams JV, Verastegui H, Hartinger SM, Mäusezahl D, Johnson M, Klemenc JM, Zhu Y, Gil AI, Lanata CF, Grigalva CG, RESPIRA PERU Group (2014) PLoS One 9: e91247 Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign. Grijalva CG, Zhu Y, Simonsen L, Griffin MR (2010) Vaccine 29: 123-9 Evidence of effectiveness from a large county-wide school-based influenza immunization campaign. Grijalva CG, Zhu Y, Griffin MR (2009) Vaccine 27: 2633-6 Recent advances in the study of human antibody responses to influenza virus using optimized human hybridoma approaches. Crowe JE (2009) Vaccine 27 Suppl 6: G47-51 Seroprevalence of seasonal and pandemic influenza A viruses in domestic cats. McCullers JA, Van De Velde LA, Schultz RD, Mitchell CG, Halford CR, Boyd KL, Schultz-Cherry S (2011) Arch Virol 156: 117-20 Chloroquine is effective against influenza A virus in vitro but not in vivo. Vigerust DJ, McCullers JA (2007) Influenza Other Respir Viruses 1: 189-92
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.